U

Universal Health Services

Manages hospitals and behavioral health facilities

Patient Care Technician

Full-TimeDeadline 9/30/27
No salary listed
Junior
Palmdale, CA, USA
In Person
Medical, Clinical & VeterinaryNursing & Frontline Patient Care

About the job

Requirements
  • Ability to sufficiently read, speak, and write English for communication and charting, write reports, effectively present information, and respond to questions from managers, patients, and the general public.
  • Ability to apply, measure, and understand electrical impulse timing and use appropriate tools.
  • Ability to define problems, collect data, establish facts, and draw valid conclusions; work under supervision and follow instructions; maintain pleasant telephone manners and neat, legible handwriting.
  • At least one year of prior Patient Care Technician experience in a healthcare setting is preferred.
  • Thorough computer skills and proper telephone and interpersonal skills.
  • High school diploma or equivalent.
  • Current Basic Life Support certification.
  • Crisis Prevention Institute training is required within 30 days of hire.
Responsibilities
  • Monitor patients in the Surgery Department as a member of the Preoperative team under the supervision of the Charge Nurse and/or Department Manager.
  • Support equipment procurement, room setup and turnover, patient transports and transfers, and resupply of sterile and unsterile supplies and equipment.
  • Perform other duties as directed.
  • Maintain a courteous and professional attitude and project a good public image.
Desired Qualifications
  • Medical terminology course preferred.
  • Computer education preferred.

About the company

U

Universal Health Services

View

Universal Health Services operates a network of acute care hospitals, behavioral health facilities, and ambulatory centers across the United States. It generates its services by acquiring and managing healthcare facilities, then integrating them under centralized operating practices to deliver patient care. The company’s offering is the management and provision of hospital and behavioral health services, with a focus on standardized clinical operations, economies of scale, and nationwide coverage. What sets UHS apart is its long history of growth through acquisitions, its size and scale in both acute and behavioral health markets, and its ability to integrate new facilities while maintaining consistent care quality. Its goal is to provide high-quality healthcare across a broad network, improve patient outcomes, and sustain long-term value for shareholders by expanding access and efficiency in hospital and behavioral health services.

Company Size

10,001+

Company Stage

IPO

Headquarters

Upper Merion Township, Pennsylvania

Founded

1978

Get referred to Universal Health Services

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • UHS posted $358.4 million Q2 2026 profit and 8.3% revenue growth.
  • Talkspace adds 6,000 therapists and access to over 200 million covered lives.
  • September 2026 investor presentations and ongoing buybacks signal management confidence and capital discipline.

What critics are saying

  • Laurel Ridge lost Medicare and Medicaid certification in April 2026, crushing facility economics.
  • Nevada litigation still threatens UHS with retrial risk after the February 25, 2026 ruling.
  • Over 30 minor-abuse lawsuits and Missouri allegations damage UHS's brand and recruiting.

What makes Universal Health Services unique

  • UHS built a rare acute-care and behavioral-health network across 40 states.
  • Talkspace closed August 17, 2026, creating UHS's first virtual-to-inpatient behavioral continuum.
  • UHS keeps expanding owned facilities, like Three Trails Behavioral Hospital in Missouri, opened September 2026.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Student Loan Assistance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Disability Insurance
  • Life Insurance
  • Pet Insurance

Company News

Watchlist News
Nov 1st, 2026
Universal Health Services Q3 earnings call highlights.

Universal Health Services Q3 earnings call highlights. Universal Health Services (NYSE:UHS) reported third-quarter adjusted earnings per share of $5.22, down 8% from a year earlier, as the company cited favorable acute-care demand, improving behavioral-health volumes and moderating labor pressures but said results fell below its internal expectations after excluding certain items. Adjusted EBITDA less noncontrolling interests totaled $625 million, compared with $671 million in the third quarter of 2025. Chief Financial Officer Steve Filton said the quarter included a $37 million net out-of-period headwind from Medicaid directed payment programs compared with the prior-year period. Results also included $47 million of supplemental Medicaid benefits not included in the company's July forecast, partly offset by $26 million in additional professional and general liability reserves, primarily related to a tentative litigation settlement involving its Cumberland facility in Virginia, and $8.5 million of Talkspace acquisition-related costs. Together, those items had a net favorable impact of $12 million. "Excluding these items, adjusted EBITDA less NCI was below our internal expectations despite modest sequential improvement," Filton said. He attributed the shortfall primarily to a slower-than-expected ramp at de novo hospitals and softer surgical trends. Acute-Care volumes rise as surgeries decline. Same-facility adjusted admissions at UHS acute-care hospitals rose 4.9% year over year, while emergency department visits increased 4.6%. The growth was broad-based geographically and benefited from capacity additions at three hospitals during the second quarter, Filton said. Same-facility surgeries, however, declined 0.7%, with inpatient and outpatient surgical cases falling at similar rates. Medical admissions substantially outpaced surgical admissions, affecting revenue mix and pricing trends. The company reported strength in cardiology, neurology and urology. Acute-care same-facility net revenue rose 4.7%, or 3.1% excluding the company's health plan. Revenue per adjusted admission declined 1.7% on a reported basis but was slightly positive after excluding the effects of out-of-period Medicaid supplemental benefits and a shift from exchange-covered patients to uninsured volumes. After adjusting for those factors and the higher medical-to-surgical mix, UHS estimated acute-care rate growth of about 3%, consistent with recent quarters. * Acute-care salaries, wages and benefits expense per adjusted admission increased 2.1%. * Supply expense per adjusted admission decreased 2.3%. * Acute-care segment EBITDA declined 4.5% on a reported basis but increased 2.9% excluding out-of-period supplemental-program effects from both years. Health insurance exchange volumes fell 17% from the prior-year quarter, with a similar increase in self-pay volumes. Filton said exchange trends had an impact of slightly less than $25 million during the quarter, in line with the company's July outlook. De novo hospitals take longer to mature. UHS said Palm Beach Gardens Hospital in Florida remains in the early stages of building volumes across service lines. Startup losses improved each month during the third quarter, and the company expects conditions to improve as Florida enters its seasonally busier winter period. At Cedar Hill Regional Medical Center in Washington, D.C., operating losses were sequentially similar excluding supplemental payments. UHS now expects the hospital to reach operational break-even in the first half of 2027, later than its prior expectation for the fourth quarter of 2026. Filton said Cedar Hill has maintained busy emergency-room activity but has taken longer to develop surgical and procedural volumes because of a limited physician infrastructure in the surrounding Ward 7 and Ward 8 communities. UHS is working to establish primary-care and specialty practices near the hospital and its medical office building. Combined operating losses from Cedar Hill, Palm Beach Gardens and Laurel Ridge Treatment Center in San Antonio are expected to total $80 million to $100 million in 2026, according to Filton. He said Cedar Hill has been losing about $10 million monthly, while Palm Beach Gardens lost about $15 million during the third quarter. Behavioral health growth and Talkspace integration. In behavioral health, same-facility net revenue increased 4.0%, supported by 2.1% growth in both revenue per adjusted patient day and adjusted patient days. The segment's volumes improved modestly from recent quarters, which management attributed to steady demand and a greater focus on outpatient levels of care. Behavioral-health results included Talkspace, acquired Aug. 17, and a U.K. acquisition completed in July. Talkspace's contribution to third-quarter earnings was immaterial because the transaction closed partway through the quarter. President and CEO Marc Miller said UHS has begun integrating Talkspace through technology deployment, referral pathways from behavioral-health facilities and more flexible market-based outpatient services, including virtual intensive outpatient program offerings. The company expects the strategic benefits of the acquisition to emerge over the next 12 to 24 months. Filton said Talkspace is expected to be slightly accretive during its first 12 months under UHS ownership, largely reflecting limited duplicative-cost savings. The larger opportunity is expected to come from revenue synergies as the companies connect Talkspace's lower-acuity virtual-care population with UHS's higher-acuity behavioral-health network. UHS continues to expect Laurel Ridge to regain certification during 2027. The facility generated $20 million to $25 million in pretax income before losing certification, Filton said, and is expected to lose $5 million to $10 million per quarter while it remains open without certification and treats a limited number of patients. Cash flow, capital spending and 2027 considerations. Cash generated from operating activities totaled $637 million in the third quarter, compared with $381 million a year earlier. UHS spent $214 million on capital expenditures during the quarter and expects full-year capital spending to come in slightly below $1 billion. With several acute-care de novo and expansion projects completed, the company expects capital expenditures to moderate toward $800 million beyond 2026. Filton said that figure would still include substantial expansionary spending on capacity, beds, operating rooms, emergency rooms, robotics and outpatient access points. UHS repurchased 1.35 million shares for $242 million during the quarter, bringing year-to-date repurchases to $690 million. As of Sept. 30, the company had $735 million remaining under its authorization. UHS ended the quarter with $169 million in cash, $5.7 billion in total debt and leverage of 2.17 times. The company reiterated the financial and operating outlook ranges it issued in July but said it expects results toward the lower end of those ranges, reflecting the pace of de novo hospital ramp-ups. Looking ahead to 2027, Filton said UHS sees potential to recover a meaningful portion of the losses from its de novo facilities and Laurel Ridge. But he also identified regulatory pressures, including Medicaid supplemental-payment reductions, exchange enrollment changes and Medicaid work requirements. UHS estimates that Medicaid supplemental-payment reductions could create a $175 million to $200 million headwind in 2027, including the nonrecurrence of prior-year directed-payment benefits recorded during 2026. Annualizing the second-half 2026 exchange run rate would create an additional $15 million headwind, with further risk depending on enrollment trends. About universal Health Services (NYSE:UHS). Universal Health Services, Inc (NYSE: UHS) is a healthcare services company that owns and operates hospitals, outpatient facilities and other healthcare providers. Its operations are focused primarily on acute care and behavioral health services. The company's acute care operations include general and specialty hospitals, ambulatory surgery centers, emergency departments, physician practices and other outpatient services. Its behavioral health business provides inpatient and outpatient treatment for mental health conditions, substance-use disorders and related needs. Universal Health Services serves patients across the United States and Puerto Rico, with additional behavioral health operations in the United Kingdom.

Yahoo Finance
Oct 30th, 2026
UHS fair value estimate cut to $189.94 from $194.35 as analysts split on 2026 outlook

Analysts have trimmed their fair value estimate for Universal Health Services (UHS) to $189.94 a share, down from $194.35. The change follows a tough third quarter, lower 2026 earnings guidance, and about $200 million in one-off items, including the decertification of a San Antonio behavioural facility by the Centers for Medicare & Medicaid Services. Softer elective surgery demand across the hospital sector also weighs on the stock. BofA cut its price target after an EBITDA miss. RBC Capital and Baird also trimmed theirs, though RBC says underlying volume trends remain healthy. Guggenheim sees the lower guidance as a possible reset that could support cleaner execution in the fourth quarter.

Yahoo Finance
Oct 29th, 2026
UHS Q3 adjusted EPS falls 8% to $5.22 as new hospitals ramp slowly, guidance held

Universal Health Services (UHS) reported third-quarter adjusted earnings per share of $5.22, down 8% from a year earlier. Adjusted EBITDA less noncontrolling interests fell to $625 million from $671 million. Chief financial officer Steve Filton blamed slower ramp-ups at new hospitals and weaker surgical trends. UHS kept its full-year outlook but expects results near the lower end. Same-facility acute-care admissions rose 4.9%, while surgeries fell 0.7%. Cedar Hill's break-even target moved to the first half of 2027. UHS expects combined 2026 losses of $80 million to $100 million from new facilities and Laurel Ridge. It also sees a potential 2027 headwind of $175 million to $200 million from Medicaid supplemental-payment cuts.

Healthcare Dive
Oct 29th, 2026
Softer surgery volumes, hospital woes dampened UHS' Q3 earnings.

Softer surgery volumes, hospital woes dampened UHS' Q3 earnings. An increasing shift toward outpatient surgeries and slower-than-expected ramps to profitability at some of its hospitals dinged Universal Health Services earnings in the third quarter. Published Oct. 29, 2026 Dive brief: * Hospital operator Universal Health Services said it now expects earnings results for 2026 to end up on the lower range of its expectations after surgeries declined and some of its hospitals struggled in the third quarter. * Although hospital admissions rose overall, UHS executives said on a call with investors Wednesday that an increasing consumer shift to outpatient care dinged surgeries in its inpatient-heavy portfolio. * Other hospital chains have called out declining surgeries, including HCA Healthcare, as more patients lose insurance and others abstain due to cost. Dive insight: Patients have been increasingly getting surgeries in outpatient facilities, including ambulatory care centers and physician offices, enticed by lower costs and more convenient care options. Hospital operators have been attempting to capitalize on that shift, buying outpatient facilities and integrating them into their networks. UHS's portfolio, which includes 30 inpatient acute care hospitals and over 340 inpatient behavioral health facilities, skews more inpatient. Most of its medical admissions, meaning those that aren't surgeries, come through UHS' emergency rooms and surgeries tend to be elective, CFO Steve Filton said. Surgeries are a lucrative service line for operators, and a decline in volumes can ding earnings: In the third quarter, UHS' same-facility surgeries declined 0.7% over the prior year period. At the same time, medical admissions "significantly outpaced" surgery volumes, according to Filton, (acute care volumes increased 4.3%), which brought down UHS' net revenue per admissions. Although surgeries have been shifting more to outpatient, elective procedures across the board have been declining as patients postpone care due to cost and more people lose health insurance. Both inpatient and outpatient surgeries declined by similar levels, according to Filton. UHS reported $308 million in net income during the third quarter, an approximately 17% decrease from the prior year. Revenues increased over 5% to $4.7 billion. Slower-than-expected progress on some of its new hospitals also pressured UHS' earnings in the quarter. In Washington D.C., a hospital that UHS built in partnership with the city is struggling to become profitable. Executives said Cedar Hill Regional Medical Center is expected to break even on its finances in the first half of 2027, after executives again pushed back the timeline for profitability. Cedar Hill was originally supposed to break even during the first half of this year before the timeline was pushed back to the fourth quarter of 2026. Filton said Cedar Hill's physicians are in the early stages of developing their networks in an area that was historically a healthcare desert. In the meantime, the facility is losing roughly $30 million per quarter, executives said. Florida-based Alan B. Miller Medical Center, an acute care hospital that UHS opened in May, is also causing a drag on UHS' earnings. The hospital is in the "early stages" of ramping up volumes, but executives said they expect that trend to accelerate entering the busier flu and winter season. The hospital, located in Palm Beach Gardens, Florida, was a $15 million drag in the third quarter, executives said. Struggles with those two hospitals, combined with another behavioral health facility in Texas that lost its Medicare certification, are expected to contribute $80 million to $100 million in losses this year, Filton said. "Taken together, Palm Beach Gardens and Cedar Hill are progressing, but their pace of maturation remains an important factor in the timing of margin improvement for the acute care segment," Filton said. Executives said they expect UHS to end up at the lower end of its guidance range this year. Last quarter, UHS said it expected to notch $18.5 billion to $18.76 billion in revenue this year, and $2.6 billion to $2.7 billion in pretax income minus some other costs. On the exchange front, executives said patients formerly insured on Affordable Care Act plans are still going uninsured at almost a 1-to-1 rate, causing a predicted loss of slightly less than $25 million in the quarter. Exchange volumes were down 17% from the prior year. The decline in exchange volumes, and rise in uninsured patients, has caused billion-dollar losses at other hospital chains. UHS has less exposure than some larger operators, and expects to lose about $85 million from the trend this year.

Seeking Alpha
Oct 28th, 2026
UHS signals 2027 Medicaid supplemental headwind of $175M-$200M while reiterating 2026 outlook toward low end.

UHS signals 2027 Medicaid supplemental headwind of $175M-$200M while reiterating 2026 outlook toward low end. Oct 28, 2026, 12:41 PM ET Universal Health Services, Inc. (UHS) Stock AI-Generated Earnings Calls Insights Earnings Call Insights: Universal Health Services (UHS) Q3 2026 Management view. * "Overall, underlying performance in the third quarter reflected sequential improvement in several areas. Acute Care demand remained favorable. Behavioral Health volumes demonstrated an increase relative to recent quarters, and labor trends continue to moderate." (CEO, President & Director Marc Miller) * "Third quarter results included certain items that were not reflected in the outlook we provided with our second quarter results in July." (CEO, President & Director Marc Miller) Miller highlighted items including "the benefit from the expansion of existing Medicaid supplemental programs in several states, partially offset by other nonrecurring litigation and transaction costs." * "In Behavioral Health, we completed the Talkspace acquisition on August 17 and began executing the integration plan." (CEO, President & Director Marc Miller) Miller described a phased integration focused on technology to improve transitions of care, referral flows into Talkspace for therapy and medication management, and development of "a virtual intensive outpatient program, or IOP." * "At Laurel Ridge... we currently expect during 2027." (CEO, President & Director Marc Miller) Miller said work toward recertification continued and that Q3 financial impact was consistent with the company's July outlook assumptions. * "The company reported adjusted EPS of $5.22 for the third quarter of 2026, representing a decline of 8% year-over-year." (Executive VP, CFO & Secretary Steve Filton) Filton also said, "Third quarter adjusted EBITDA less NCI was $625 million as compared to $671 million in the third quarter of 2025." Outlook. * "We are reiterating the financial and operating forecast ranges issued with our second quarter results in July." (Executive VP, CFO & Secretary Steve Filton) Filton added, "we currently expect results to be towards the lower end of these ranges," citing year-to-date trends and the ramp of Washington, D.C. and Palm Beach Gardens. * On early 2027 framing (ahead of formal February guidance), Filton said, "Cumulatively, these facilities are expected to contribute operating losses of $80 million to $100 million in 2026," referring to Laurel Ridge and the two acute care de novos. * Filton also provided a preliminary regulatory headwind estimate: "As it relates to Medicaid supplemental payments, we estimate the 2027 headwind will be approximately $175 million to $200 million." * On exchanges, Filton said, "Annualizing the second half 2026 run rate would create a $15 million headwind in 2027," while noting open enrollment could change the outcome. Financial results. * Filton said Q3 included a net favorable $12 million impact from three items not contemplated in July guidance: "$47 million of supplemental Medicaid benefit," "$26 million of additional professional and general liability reserves," and "$8.5 million of transaction-related costs associated with the Talkspace acquisition." * Filton said, "Excluding these items, adjusted EBITDA less NCI was below our internal expectations," driven by "a slower-than-expected ramp-up at our de novo hospitals and softer-than-expected surgical trends." * Acute Care same-facility demand remained positive: "adjusted admissions... increased 4.9%," and "emergency department visits increased 4.6%," while "surgeries decreased 0.7%." (Executive VP, CFO & Secretary Steve Filton) * Behavioral Health same-facility metrics improved modestly: "same-facility net revenue increased 4.0%," with "a 2.1% increase in... revenue per adjusted patient day" and "a 2.1% increase in... adjusted patient days." (Executive VP, CFO & Secretary Steve Filton) * Cash flow and capital allocation remained active. Filton said, "Third quarter cash generated from operating activities was $637 million," capex was "$214 million," and "we acquired 1.35 million of our own shares... at a total cost of $242 million." Q&A. * Albert Rice, UBS Investment Bank: asked for "puts and takes for next year" including DPP and exchange headwinds; Executive VP, CFO & Secretary Filton: said the company will give "full comprehensive 2027 guidance in February," and estimated "the 2027 headwind... approximately $175 million to $200 million," while citing exchange run-rate "$15 million headwind in 2027." * Ann Hynes, Mizuho: asked what is "driving that slower ramp" at the two acute facilities; Executive VP, CFO & Secretary Filton: said Cedar Hill has had "busy emergency room activity," but "what has lagged has been a busier surgical and procedural schedule," attributing it to "a lack of physician infrastructure" in Ward 7 and 8; for Palm Beach Gardens, he cited opening "in the beginning of the summer" after "construction delays." * Justin Lake, Wolfe Research: asked to break down losses and Laurel Ridge timeline; CEO, President & Director Miller: "we don't have an exact date in 2027"; Executive VP, CFO & Secretary Filton: said Laurel Ridge prior pretax income was "in the $20 million, $25 million range," current losses "$5 million or $10 million a quarter," Cedar Hill "roughly $10 million a month," and Palm Beach Gardens "about $15 million in this quarter." * Kevin Fischbeck, BofA Securities: pressed on what's causing "acceleration" of surgical shift; Executive VP, CFO & Secretary Filton: "I don't know that I have a great explanation," but described compounding impacts in GI, including difficulty "to get GIs to cover our emergency rooms," leading to diversion. Sentiment analysis. * Analysts' tone was slightly negative to pressing around de novo ramps, surgical softness, and 2027 headwinds, with questions like "what's driving that loss versus your expectations" (Ann Hynes, Mizuho) and requests to explain the "acceleration" in the shift out of hospital surgeries (Kevin Fischbeck, BofA). * Management tone was neutral to slightly positive in prepared remarks, emphasizing sequential improvement and integration progress, but more cautious on forward visibility in Q&A, including "we don't have an exact date in 2027" (CEO, President & Director Miller) and "I don't know that I have a great explanation" (Executive VP, CFO & Secretary Filton). * Versus last quarter, management continued to emphasize exchange pressure consistency and de novo ramp timing, but Q3 included more explicit preliminary 2027 sizing (Medicaid supplemental headwind and facility-loss recovery potential) than was discussed in Q2. Quarter-over-quarter comparison. * Q3 reiterated the July (Q2) 2026 forecast ranges, with Filton adding that results were expected "towards the lower end," whereas Q2 introduced an "updated 2026 forecast... in a range of $2.61 billion to $2.72 billion" for adjusted EBITDA less NCI. (Executive VP, CFO & Secretary Filton) * Talkspace shifted from "pending" in Q2 ("we expect to close in mid-August") to closed in Q3 ("completed the Talkspace acquisition on August 17"), with management moving from integration planning to execution and phased rollout. (CEO, President & Director Marc Miller) * De novo timing expectations moved out at Cedar Hill: in Q3, Filton said the hospital is now expected to reach "operational breakeven in the first half of 2027 compared with our prior expectations of the fourth quarter of 2026." Risks and concerns. * Filton identified "softer-than-expected surgical trends" and "slower-than-expected ramp-up at our de novo hospitals" as key operational risks to near-term margins. * On 2027 regulatory risks, Filton flagged "reductions to Medicaid supplemental funding," potential "Medicaid work requirements," and uncertainty tied to exchange enrollment, while stating a baseline assumption that "a vast majority of Behavioral Health patients and a meaningful portion of our Acute Care patients could be exempt" under medical frailty exemptions. Final takeaway. Management reiterated 2026 guidance ranges but said results were tracking toward the lower end as de novo hospitals mature and surgical mix remains pressured. Executives framed Talkspace as a phased integration aimed at building outpatient continuity and referral pathways over "the next 12 to 24 months," while also previewing material 2027 swing factors: potential recovery of an estimated $80 million to $100 million of 2026 operating losses at Laurel Ridge and the de novos, alongside an estimated $175 million to $200 million Medicaid supplemental headwind and a $15 million exchange run-rate headwind if current trends persist. Fresh Stock Ideas, Every Day Explore diverse investing perspectives with daily analysis from experts across the market. More on Universal Health Services. Seeking Alpha's Disclaimer: This article was automatically generated by an AI tool based on content available on the Seeking Alpha website, and has not been curated or reviewed by humans. Due to inherent limitations in using AI-based tools, the accuracy, completeness, or timeliness of such articles cannot be guaranteed. This article is intended for informational purposes only. Seeking Alpha does not take account of your objectives or your financial situation and does not offer any personalized investment advice. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank.